Insiders · GLSI

GLSI insider transactions

Greenwich LifeSciences Inc. (GLSI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for GLSI

• 139d
  CEO and CFO Patel Snehal bought $53,694 worth of shares (1,800 units at $29.83), increasing direct ownership by 0.03% to 5,604,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 140d
  CEO and CFO Patel Snehal bought $79,866 worth of shares (2,900 units at $27.54), increasing direct ownership by 0.05% to 5,602,302 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 149d
  CEO and CFO Patel Snehal bought $91,848 worth of shares (4,300 units at $21.36), increasing direct ownership by 0.08% to 5,599,402 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 152d
  CEO and CFO Patel Snehal bought $63,017 worth of shares (2,900 units at $21.73), increasing direct ownership by 0.05% to 5,595,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 166d
  CEO and CFO Patel Snehal bought $51,742 worth of shares (4,100 units at $12.62), increasing direct ownership by 0.07% to 5,592,202 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 187d
  CEO and CFO Patel Snehal bought $38,502 worth of shares (4,600 units at $8.37), increasing direct ownership by 0.08% to 5,588,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 198d
  SEC Form 4 filed by CEO and CFO Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 203d
  CEO and CFO Patel Snehal bought $89,358 worth of shares (10,600 units at $8.43), increasing direct ownership by 0.19% to 5,583,502 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 211d
  CEO and CFO Patel Snehal bought $21,298 worth of shares (2,300 units at $9.26), increasing direct ownership by 0.04% to 5,572,902 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 400d
  CEO and CFO Patel Snehal bought $35,568 worth of shares (3,600 units at $9.88), increasing direct ownership by 0.06% to 5,570,602 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 407d
  CEO and CFO Patel Snehal bought $48,492 worth of shares (5,400 units at $8.98), increasing direct ownership by 0.10% to 5,567,002 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 421d
  CEO and CFO Patel Snehal bought $32,760 worth of shares (3,600 units at $9.10), increasing direct ownership by 0.06% to 5,561,602 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 422d
  CEO and CFO Patel Snehal bought $48,015 worth of shares (5,500 units at $8.73), increasing direct ownership by 0.10% to 5,558,002 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 506d
  CEO and CFO Patel Snehal bought $31,275 worth of shares (2,500 units at $12.51), increasing direct ownership by 0.05% to 5,552,502 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 511d
  CEO and CFO Patel Snehal bought $39,391 worth of shares (2,900 units at $13.58), increasing direct ownership by 0.05% to 5,550,002 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 512d
  CEO and CFO Patel Snehal bought $44,030 worth of shares (3,400 units at $12.95), increasing direct ownership by 0.06% to 5,547,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 513d
  CEO and CFO Patel Snehal bought $23,940 worth of shares (2,000 units at $11.97), increasing direct ownership by 0.04% to 5,543,702 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 516d
  CEO and CFO Patel Snehal bought $27,264 worth of shares (2,400 units at $11.36), increasing direct ownership by 0.04% to 5,541,702 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 517d
  CEO and CFO Patel Snehal bought $35,584 worth of shares (3,200 units at $11.12), increasing direct ownership by 0.06% to 5,539,302 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by VP Clinical Reg Affairs Thompson Jaye

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by Director Mcwilliams David

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by Director Rothe Eric

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by Chief Medical Officer Daugherty Frank Joseph

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by CEO and CFO Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 523d
  SEC Form 4 filed by Director Hallock Kenneth

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 555d
  VP Clinical Reg Affairs Thompson Jaye bought $12,910 worth of shares (1,000 units at $12.91), increasing direct ownership by 0.38% to 264,148 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 611d
  CEO and CFO Patel Snehal bought $21,945 worth of shares (1,500 units at $14.63), increasing direct ownership by 0.03% to 5,536,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 625d
  VP Clinical Reg Affairs Thompson Jaye bought $11,080 worth of shares (800 units at $13.85), increasing direct ownership by 0.30% to 263,148 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 664d
  CEO and CFO Patel Snehal bought $27,620 worth of shares (2,000 units at $13.81), increasing direct ownership by 0.04% to 5,534,602 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 665d
  CEO and CFO Patel Snehal bought $72,490 worth of shares (5,500 units at $13.18), increasing direct ownership by 0.10% to 5,532,602 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 667d
  VP Clinical Reg Affairs Thompson Jaye bought $15,150 worth of shares (1,000 units at $15.15), increasing direct ownership by 0.38% to 262,348 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 679d
  CEO and CFO Patel Snehal bought $23,835 worth of shares (1,500 units at $15.89), increasing direct ownership by 0.03% to 5,527,102 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 681d
  VP Clinical Reg Affairs Thompson Jaye bought $16,000 worth of shares (1,000 units at $16.00), increasing direct ownership by 0.38% to 261,348 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 716d
  CEO and CFO Patel Snehal bought $2,499,998 worth of shares (174,825 units at $14.30), increasing direct ownership by 3% to 5,525,602 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 791d
  Patel Snehal bought $57,240 worth of shares (3,000 units at $19.08), increasing direct ownership by 0.06% to 5,350,777 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 799d
  Patel Snehal bought $49,950 worth of shares (2,500 units at $19.98), increasing direct ownership by 0.05% to 5,347,777 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 803d
  Patel Snehal bought $26,520 worth of shares (1,500 units at $17.68), increasing direct ownership by 0.03% to 5,345,277 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 818d
  Patel Snehal bought $43,715 worth of shares (3,500 units at $12.49), increasing direct ownership by 0.07% to 5,343,777 units (SEC Form 4) (Amendment)

  4/A - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 818d
  Patel Snehal bought $380,945 worth of shares (30,500 units at $12.49), increasing direct ownership by 0.57% to 5,343,777 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 819d
  Patel Snehal bought $53,423 worth of shares (4,100 units at $13.03), increasing direct ownership by 0.08% to 5,340,277 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 833d
  Patel Snehal bought $120,528 worth of shares (10,800 units at $11.16), increasing direct ownership by 0.20% to 5,336,177 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 834d
  Patel Snehal bought $140,589 worth of shares (12,700 units at $11.07), increasing direct ownership by 0.24% to 5,325,377 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 932d
  Patel Snehal bought $50,838 worth of shares (5,000 units at $10.17), increasing direct ownership by 0.09% to 5,312,677 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 939d
  Patel Snehal bought $31,885 worth of shares (3,500 units at $9.11), increasing direct ownership by 0.07% to 5,307,677 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 946d
  Thompson Jaye bought $4,285 worth of shares (500 units at $8.57), increasing direct ownership by 0.19% to 260,348 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 947d
  Patel Snehal bought $19,925 worth of shares (2,500 units at $7.97), increasing direct ownership by 0.05% to 5,304,177 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 965d
  Patel Snehal bought $9,070 worth of shares (1,000 units at $9.07), increasing direct ownership by 0.02% to 5,299,177 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 972d
  Patel Snehal bought $17,260 worth of shares (2,000 units at $8.63), increasing direct ownership by 0.04% to 5,298,177 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 979d
  Thompson Jaye bought $5,226 worth of shares (600 units at $8.71), increasing direct ownership by 0.23% to 259,848 units (SEC Form 4)

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 986d
  SEC Form 4: Patel Snehal bought $35,800 worth of shares (4,000 units at $8.95), increasing direct ownership by 0.08% to 5,296,177 units

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 994d
  SEC Form 4: Patel Snehal bought $9,480 worth of shares (1,000 units at $9.48), increasing direct ownership by 0.02% to 5,292,177 units

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1014d
  SEC Form 4: Patel Snehal bought $9,970 worth of shares (1,000 units at $9.97), increasing direct ownership by 0.02% to 5,291,177 units

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1030d
  SEC Form 4: Patel Snehal bought $21,100 worth of shares (2,000 units at $10.55), increasing direct ownership by 0.04% to 5,290,177 units

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1044d
  SEC Form 4 filed by Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1052d
  SEC Form 4 filed by Thompson Jaye

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1112d
  SEC Form 4 filed by Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1128d
  SEC Form 4 filed by Thompson Jaye

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1139d
  SEC Form 4 filed by Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1140d
  SEC Form 4 filed by Patel Snehal

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)
• 1148d
  SEC Form 4 filed by Thompson Jaye

  4 - Greenwich LifeSciences, Inc. (0001799788) (Issuer)